Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue.
JNJ January 2023 Daily Chart
In the last analysis, we predicted that the JNJ share price will continue to fall. The ideal was to make a zigzag ABC correction that would complete wave (Y) of ((Y)) and thus wave II to continue the rally. Well, the market fell building the expected structure and bounced from the 100% Fibonacci extension zone.
JNJ May 2023 Daily Chart
In the new chart, we adjust the daily count. We can see that wave I ended at 186.62 and the next 7 waves down completed wave ((W)) at 150.11. The change comes after analyzing the Dow Jones Stock Index and ETFs such as XLV and IHE. By examining these instruments, we can see that the most logical thing is for the JNJ rally to fail. Therefore, it is better to call the current rise as connector ((X)) and then see 3 more waves to the downside. We are marking 2 possibilities. The first that the price reaches 170.30 and falls or that it reaches the equal legs at 176.88 before the sellers enter the market.
XLV May 7th 2023 Daily Chart
In the latest daily update of the Health Care Select Sector SPDR Fund (XLV), we can see how the market could be developing a flat correction, and even, the wave ((B)) could build a triangle that would likewise send the fund to the downside. Near term, we see that we must finish wave (2) and for that, the price should move a little higher before entering in bearish movement. As you can see, the structure is very similar to the JNJ stock.
IHE May 7th 2023 Weekly Chart
In the iShares US Pharmaceuticals ETF (IHE) chart, we can see after completing wave I the fund fell in 3 waves to end wave ((W)). From here, the wave ((X)) has two outputs. The first is for the price to break above 190.17 (blue line) to complete a flat correction. This would be the best to have a clear corrective structure before continuing lower. The other possibility (red line) is that the wave ((X)) is a triangle. The we should see more sideways movement before continuing with the higher degree correction.
FURTHER DISCLOSURES AND DISCLAIMER CONCERNING RISK, RESPONSIBILITY
Trading in the Foreign Exchange market is a challenging opportunity where above average returns are available for educated and experienced investors who are willing to take above average risk.
However, before deciding to participate in Foreign Exchange (FX) trading, you should carefully consider your investment objectives, level of xperience and risk appetite. Do not invest or trade capital you cannot afford to lose. EME PROCESSING AND CONSULTING, LLC, THEIR REPRESENTATIVES, AND ANYONE WORKING FOR OR WITHIN WWW.ELLIOTTWAVE- FORECAST.COM is not responsible for any loss from any form of distributed advice, signal,
analysis, or content.
Again, we fully DISCLOSE to the Subscriber base that the Service as a whole, the individual Parties, Representatives, or owners shall not be liable to any and all Subscribers for any losses or damages as a result of any action taken by the Subscriber from any trade idea or signal posted on
the website(s) distributed through any form of social-media, email, the website, and/or any other electronic, written, verbal, or future form of communication . All analysis, trading signals, trading recommendations, all charts, communicated interpretations of the wave counts, and all content from any media form produced by www.Elliottwave-forecast.com and/or the Representatives are solely the opinions and best efforts of the respective author(s).
In general Forex instruments are highly leveraged, and traders can lose some or all of their initial margin funds. All content provided by www.Elliottwave-forecast.com is expressed in good faith and is intended to help Subscribers succeed in the marketplace, but it is never guaranteed. There is no “holy grail” to trading or forecasting the market and we are wrong sometimes like everyone else.
Please understand and accept the risk involved when making any trading and/or investment decision.
UNDERSTAND that all the content we provide is protected through copyright of EME PROCESSING AND CONSULTING, LLC. It is illegal to disseminate in any form of communication any part or all of our proprietary information without specific authorization.
UNDERSTAND that you also agree to not allow persons that are not PAID SUBSCRIBERS to view any of the content not released publicly. IF YOU ARE FOUND TO BE IN VIOLATION OF THESE RESTRICTIONS you or your firm (as the Subscriber) will be charged fully with no discount for one year subscription to our Premium Plus Plan at $1,799.88 for EACH person or firm
who received any of our content illegally through the respected intermediary’s (Subscriber in violation of terms) channel(s) of communication.
Headline: Johnson & Johnson (JNJ) Shares Entering a Bull Trap
The stock of Johnson & Johnson (JNJ) is entering a bull trap. This is a situation where prices may appear to be going up but fail to reach resistance levels and begin to trend downwards.
For investors in JNJ, this is an unwelcome development. The stock, which had been on a consistent upward trajectory, has seen its share price drop by almost 5% from its recent highs. After dropping from a support resistance of $165, the stock currently trades at around $158.
Analysts believe that there is now a likelihood that the stock may test its 200-day moving average at $155, which is a major indicator of resistance. The stock’s bad news about a looming lawsuit involving the company’s baby powder may have also hurt investor confidence, putting the stock in a precarious position.
Investors in Johnson & Johnson (JNJ) should proceed with caution as the stock may see a further dip in prices if the stock fails to break past the $155 support. This could mean that the bulls may not be able to prevent the stock price from decreasing.
In light of this situation, investors are advised to pursue a wait-and-see approach and wait for the dust to settle. JNJ is still one of the most reliable dividend paying stocks and a potential recovery could come on the back of good news.
However, until then, investors should investigate further before entering into any trades in JNJ shares. As such, those presently invested should remain vigilant and exercise caution when placing orders. With the right analysis, investors can avoid being caught in a potential bull trap.